Regeneron Must Pay Attys' Fees After 'Severe Misconduct'
Regeneron Pharmaceuticals Inc. must pay Kirkland & Ellis LLP-backed Merus NV attorneys' fees after engaging in "severe litigation misconduct" from the outset of infringement litigation over a patent for a genetically...To view the full article, register now.
Already a subscriber? Click here to view full article